Search

Author/Creator Mounedji, Nadjat

1. Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study. Issue 1 (January 2017)

Authors:
Passamonti, Francesco; Griesshammer, Martin; Palandri, Francesca; Egyed, Miklos; Benevolo, Giulia; Devos, Timothy; Callum, Jeannie; Vannucchi, Alessandro M; Sivgin, Serdar; Bensasson, Caroline; Khan, Mahmudul; Mounedji, Nadjat; Saydam, Guray
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study. Issue 3 (1st June 2020)

Authors:
Bachet, Jean-Baptiste; Wyrwicz, Lucjan; Price, Timothy; Cremolini, Chiara; Phelip, Jean-Marc; Portales, Fabienne; Ozet, Ahmet; Cicin, Irfan; Atlan, Dan; Becquart, Martin; Vidot, Loick; Mounedji, Nadjat; Van Cutsem, Eric; Taieb, Julien; Falcone, Alfredo
Journal:
ESMO open
Issue:
Volume 5:Issue 3(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search